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Background: Breast cancer is the most common cause of death from cancer in women in less developed regions.
Therefore, the objective of this study was to provide data on the temporal trends in female breast cancer mortality
between 1990 and 2011 and to evaluate its association with the social inequalities present in Brazil.
Methods: Breast cancer mortality data and estimates for the resident population were obtained from the Brazilian
National Health Service database for the 1990–2011 period. Age-standardized mortality rates were calculated (20–39,
40–49, 50–69 and ≥70 years) by direct standardization using the 1960 standard world population. Trends were
modeled using joinpoint regression model and linear regression. The Social Exclusion Index and the Human Development
Index were used to classify the 27 Brazilian states. Pearson’s correlation was used to describe the association between the
Social Exclusion Index and the Human DeveIopment and the variations in mortality rates in each state.
Results: Age-standardized mortality rates in Brazil were found to be stable (annual percent change [APC] = 0.3;
95% CI: −0.1 – 0.7) between 1994 and 2011. Considering the Brazilian states, significant decreases in mortality
rates were found in Rio Grande do Sul, Rio de Janeiro and São Paulo. Increases in mortality rates were most
notable in the states of Maranhão (APC = 11.2; 95 %CI: 5.8 – 16.9), Piauí (APC = 9.8; 95% CI: 7.6 – 12.1) and
Paraíba (APC = 9.3; 95% CI: 6.0 – 12.8). There was a statistically significant correlation between Social Exclusion
Index and a change in female breast cancer mortality rates in the Brazilian states between 1990 and 2011 and
between Human Development Index and mortality between 2001 and 2011.
Conclusions: Female breast cancer mortality rates are stable in Brazil. Reductions in these rates were found in
the more developed states, possibly reflecting better healthcare.
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Breast cancer is the most common cause of death from
cancer in women in less developed regions (324,000
deaths; 14.3% of the total) and the second cause of death
from cancer in women after lung cancer in the more de-
veloped regions (198,000 deaths). Despite the high inci-
dence of the disease in the developed world, mortality
rates are much lower because of favorable survival rates* Correspondence: ruffojr@terra.com.br
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unless otherwise stated.[1]. Data collected in the United States over the past two
decades show that breast cancer mortality rates have de-
creased by more than 30% since their peak in 1991;
nevertheless, breast cancer is still the most common
cause of death from cancer in women of 20 to 59 years
of age [2].
In Brazil, mortality rates range from 14 per 100,000 in
the south and southeast to 6.6 per 100,000 in the north
of the country. Nonetheless, a significant decrease has
been seen in the southeast since 1997 (APC = −0.9%)
and a non-significant decrease in the south of the coun-
try. In the other regions, although rates were lower,
there was a tendency towards an increase. The highestal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(18.8 in 1994) and in the Federal District (18.4 in 2006)
[3]. In urban areas, a significant decrease in mortality
was found in five cities compared to only one rural dis-
trict. Breast cancer mortality increased in the majority of
rural regions in Brazil with the exception of some areas
in the south and southeast of the country. A possible
reason for this disparity may be that access to treatment
is more difficult for patients living in rural areas [4].
Advances in treatment have considerably improved
the prognosis of breast cancer in recent decades, with
survival rates reaching approximately 90% for white
women in the United States [2]. Paradoxically, improve-
ments in treatment increased inequalities in health re-
sources between women living in rich countries and
those living in middle to low income countries. The
most important factors are the availability of drugs at an
accessible cost and of centers of excellence to guarantee
the efficacy and safety of treatment [5].
International initiatives have highlighted the need to
improve breast cancer treatment in developing countries
[6], with the objective of decreasing mortality by redu-
cing disparities in the access to treatment and diagnostic
methods. The high mortality rates in these countries are
known to be a consequence of the fact that diagnosis is
made at an advanced stage and that resources for treat-
ment are scarce.
The Brazilian population varies insofar as their ethnic
origin, culture and socioeconomic conditions are con-
cerned. For this reason, providing high quality healthcare
throughout the entire country is a challenge [7], and
there is a need for further epidemiological studies on
breast cancer. Therefore, the objective of this study was to
provide data on the temporal trends in female breast can-
cer mortality between 1990 and 2011 and to evaluate its
association with the social inequalities present in Brazil.
Methods
Cancer mortality data and estimates for the resident
population from 20 to 39, 40 to 49, 50 to 69 and ≥70 years
of age for the 1990 to 2011 period were obtained from the
Ministry of Health’s database (DATASUS) [8]. Breast
cancer deaths were coded according to the International
Classification of Diseases (ICD). The ninth revision of the
ICD (ICD-9) was used for the 1990–1995 period (ICD
code 174), while the 10th revision was used for the 1996–
2011 period (ICD code C50). Age-standardized mortality
rates for women of 20 years of age or more were obtained
by direct standardization based on the 1960 world
standard population. Variations in mortality were mod-
eled using standard linear regression methods, with
the age-standardized mortality coefficient as the dependent
variable and the calendar year as the independent
variable.Trends in age-adjusted breast cancer death rates were
estimated using joinpoint regression, which involves fit-
ting a series of joined straight lines on a logarithmic scale
to the trends in the annual age-adjusted mortality rates [9]
using the Joinpoint Regression Program (version 4.0). A
maximum of 3 joinpoints was allowed in models for the
period 1990 through 2011. The resulting trends were
described by the slope of the line segment or the an-
nual percent change (APC). The average APC (AAPC)
was estimates as a weighted geometric average of the
APCs, with the weights equal to the length of each line
segment during the prespecified, fixed interval. The
95% confidence intervals (95% CIs) were calculated for
each estimated APC. If these intervals excluded zero,
then the APCs were statistically significant (p < .05).
The Social Exclusion Index (SEI) and the Human
Development Index (HDI), which ranges from 0 (worst)
to 1 (best), were used to classify the 27 Brazilian states.
The human development index (HDI) is a composite stat-
istic of life expectancy, education and income indices used
to rank countries into four tiers of human development,
taking into consideration a concept of well-being viewed
in terms of capability. The lowest HDI was in the state of
Alagoas (0.631), while the highest was in the Federal Dis-
trict (0.824) (Figure 1a). The SEI was based on three di-
mensions: suitable life conditions, knowledge and youth
vulnerability, as described previously [10]. The lowest SEI
was in the state of Maranhão (0.197) and the highest in
the Federal District (0.850) (Figure 1b).
Pearson correlation coefficients were used to describe
the correlation between the SEI and the variations in
mortality rates in each Brazilian state for the entire
evaluation period, the HDI (2000) for the 1990–2000
period and the HDI (2010) for the 2001–2010 period.
For all the statistical tests, a type 1 (α) error of 5% was
adopted.
This project has been approved by the Ethics Committee
on Human and Animal Research of the Hospital of the
Federal University of Goiás (Protocol number 75793).
Results
Between 1990 and 2011, 195,596 deaths from breast can-
cer were registered for Brazilian women of 20 years of
age or more. By age group, the highest rates were in the
group of Brazilian women of 70 years of age or older
(Table 1). In Brazil, the highest age-adjusted mortality
rate was in 2006 (12.7/100,000) and the lowest in 1991
(10.2/100,000). The highest mortality rate in the entire
period evaluated was found in the state of Rio de Janeiro
(17.2/100,000) and the lowest in the state of Maranhão
(3.2/100,000) (Figure 2).
A statistically significant increase in breast cancer mortal-
ity rates in Brazil, was found for the following age groups:
20–39 years (APC= 0.7; 95% CI: 0.3 – 1.1, p < 0.01), 50–69
a Map of the Human Development Index, Brazil, 2000 and 2010.
b
 Map of social exclusion, Brazil, 2000.
Figure 1 Map of Brazil. a. Human Development Index, 2000 and 2010. b. Social Exclusion Index, 2000. The lowest SEI was in the state of
Maranhão (0.197) and the highest in the Federal District (0.850) Acre (AC), Alagoas (AL), Amapá (AP), Amazonas (AM), Bahia (BA), Ceará (CE), Distrito
Federal (DF), Espírito Santo (ES), Goiás (GO), Maranhão (MA), Mato Grosso (MT), Mato Grosso do Sul (MS), Minas Gerais (MG), Pará (PA), Paraíba (PB),
Paraná (PR); Pernambuco (PE), Piauí (PI), Rio de Janeiro (RJ), Rio Grande do Norte (RN), Rio Grande do Sul (RS), Rondônia (RO), Roraima (RR), Santa
Catarina (SC), São Paulo (SP), Sergipe (SE), Tocantins (TO).
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Table 1 Age-specific and age-standardized world female
breast cancer mortality rates according to year: Brazil,
1990-2011








≥70 years ≥20 years
1990 2.5 16.0 34.0 56.7 10.3
1991 2.3 16.3 33.5 56.7 10.2
1992 2.4 16.5 34.6 57.1 10.5
1993 2.4 17.8 35.9 62.3 11.0
1994 2.7 18.5 37.5 65.5 11.6
1995 2.7 17.7 36.9 65.6 11.4
1996 2.5 16.3 34.5 62.0 10.7
1997 2.4 17.9 36.5 65.5 11.3
1998 2.6 17.7 37.4 71.7 11.7
1999 2.7 17.7 37.0 72.8 11.7
2000 2.5 16.7 33.8 62.5 10.6
2001 2.5 16.7 35.3 64.3 10.9
2002 2.6 16.7 37.0 64.8 11.3
2003 2.5 17.5 36.9 70.7 11.5
2004 2.6 17.7 38.9 72.2 11.9
2005 2.5 18.3 39.2 74.5 12.1
2006 2.6 18.1 41.4 79.8 12.7
2007 2.6 16.5 35.4 68.2 11.1
2008 2.8 17.1 37.2 70.1 11.6
2009 2.9 17.0 36.0 69.1 11.4
2010 2.9 17.2 37.2 69.4 11.6
2011 3.0 17.9 38.0 72.2 12.0
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of age or older (APC= 1.0; 95% CI: 0.6 – 1.5, p < 0.01).
There was also a trend towards an increase in the 40–49
years age group; however this increase was not statistically
significant: (APC= 0.2; 95% CI: −0.0 – 0.5, p = 0.1).
Female breast cancer mortality rates have remained
stable (APC = 0.3; 95% CI: −0.1 – 0.7) in Brazil, between
1994 and 2011 (Table 2). A statistically significant de-
crease in mortality was found in the states of Rio Grande
do Sul, Rio de Janeiro and São Paulo (Table 2).
Increasing trends in mortality rates were most notable
in the states of Maranhão (APC = 11.2; 95% CI: 5.8 –
16.9) between 2002 and 2011, Piauí (APC = 9.8; 95% CI:
7.6 – 12.1), between 1997 and 2011 and Paraíba (APC =
9.3; 95% CI: 6.0 – 12.8) between 1999 and 2011 (Table 2).
Linear regression models showed disparities in female
breast cancer mortality trends in Brazil. There was no
statistically significant correlation between HDI and a
change in the female breast cancer mortality rates in Brazil(r = 0.28; p = .156) between 1990 and 2000 (Figure 3a).
However, for the 2001–2011 period, a statistically signifi-
cant correlation was found between HDI and the change
in female breast cancer mortality rates in the country
(r = −0.79; p < .001) (Figure 3b) and also between SEI
and mortality (r = −0.75; p < 0.001) for the overall
period (Figure 4).
Discussion
To the best of our knowledge, this is the first report to
analyze the temporal trends in female breast cancer
mortality in Brazil and to correlate them with social in-
equalities. The study of mortality trends is useful for
monitoring changes in the epidemiological profile of the
population.
The female breast cancer mortality rates in Brazil de-
scribed in the present study are similar to rates found
earlier in Chile, Costa Rica, Cuba, Puerto Rico and
Venezuela [11], values expected for developing countries
[1]. However, they are higher than rates found in
Colombia, Ecuador and Mexico (<10/100,000) [11]. Fe-
male breast cancer mortality trends have remained stable
in the country since 1994, this finding being in agree-
ment with reports from another study (APC = 0.4%) [3].
A marked disparity was found between the different
Brazilian states with respect to mortality rates, which
ranged from 2-5/100,000 in the less developed areas of
the country to 12-18/100,000 in the more developed re-
gions. Although rates were higher in these states, there
was a significant decrease in mortality rates in Rio Grande
do Sul, Rio de Janeiro and São Paulo, similar to that seen
in developed countries such as the US (APC = −1.9%) [2]
and Portugal (APC = −0.9%) [12], and also in some devel-
oping countries such as Singapore (APC = −1.50%) [13].
Nevertheless, the mortality rates here are lower than those
found in these countries.
One possible hypothesis for the lower breast cancer
mortality rates found in Brazil may be under-notification.
It is known that the cancer registries cover only 6% of the
Latin American population in comparison to 96% in the
US and 32% in Europe [14]. There are 17 population-
based cancer registries in the country, 16 of which are lo-
cated in state capital cities. Data collection varies from
registry to registry and also from one year to another
within a single registry [8].
Another hypothesis for the patterns of inequality in
health found in Brazil with respect to breast cancer mor-
tality may be the lack of available resources for treat-
ment in the less developed states or the inaccessibility of
the majority of the population to treatment. In some
cases, the situation would be comparable to that found
in Nigeria where there is no specific screening program
within the national healthcare system and only two
hospitals offering tertiary treatment (radiotherapy and
Figure 2 Female breast cancer mortality rates in the states of Brazil from 1990 to 2011.
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Table 2 Temporal trends in mortality from female breast cancer in the states of Brazil between 1990 and 2011
States Trend 1 Trend 2 AAPC
Years APC (95% CI; p-value) Years APC (95% CI; p-value) 2002-2011
Paraná 1990-2005 1.2* (0.6 to 1.9; p < 0.01) 2005-2011 −1.2 (−3.8 to 1.4; p = 0.33) −0.4
Santa Catarina 1990-1994 6.6* (0.2 to 13.5; p = 0.04) 1994-2011 0.0 (−0.7 to 0.7; p = 0.92) 0.0
Rio Grande do Sul 1990-1993 4.6 (−4.5 to 14.6; p = 0.31) 1993-2011 −0.7* (−1.3 to −0.1; p = 0.01) −0.7*
Espírito Santo 1990-2011 1.8* (0.9 to 2.8; p < 0.01) 1.8*
Rio de Janeiro 1990-2011 −0.5* (−0.8 to −0.2; p < 0.01) −0.5*
São Paulo 1990-1998 1.7* (0.0 to 3.4; p = 0.04) 1998-2011 −1.7* (−2.4 to −0.9; p < 0.01) −1.7*
Minas Gerais 1990-2011 0.5* (0.0 to 1.0; p = 0.04) 0.5*
Goiás 1990-2011 2.2* (1.3 to 3.1; p < 0.01) 2.2*
Mato Grosso do Sul 1990-2011 1.7* (0.2 to 3.2; p = 0.02) 1.7*
Mato Grosso 1990-2011 4.2* (2.9 to 4.5; p < 0.01) 4.2*
Distrito Federal 1990-2011 −0.2 (−1.0 to 0.7; p = 0.68) −0.2
Amazonas 1990-2011 2.1* (0.6 to 3.7, p < 0.01) 2.1*
Pará 1990-2011 2.2* (1.0 to 3.3, p < 0.01) 2.2*
Rondônia 1990-2011 6.0* (3.4 to 8.7, p < 0.01) 6.0*
Acre 1993-2011 0.8 (−2.6 to 4.2; p = 0.64) 0.8
Amapá 1997-2011 4.6 (−1.9 to 11.6, p = 0.15) 4.6
Roraima 1990-2011 2.8 (−1.6 to 7.4; p = 0.20) 2.8
Tocantins 1990-2011 6.3* (3.8 to 8.9; p < 0.01) 6.3*
Bahia 1990-2001 1.2 (−0.1 to 2.6; p = 0.06) 2001-2011 4.4* (2.9 to 6.0; p < 0.01) 4.4*
Rio Grande do Norte 1990-2011 2.4* (1.3 to 3.6; p < 0.01) 2.4*
Maranhão 1990-2002 2.6 (−0.7 to 5.9; p < 0.11) 2002-2011 11.2* (5.8 to16.9; p < 0.01) 11.2*
Piauí 1990-1997 −1.6 (−7.3 to 4.5; p = 0.58) 1997-2011 9.8* (7.6 to 12.1; p < 0.01) 9.8*
Paraíba 1990-1999 0.8 (−3.9 to 5.8; p = 0.72) 1999-2011 9.3* (6.0 to 12.8; p < 0.01) 9.3*
Alagoas 1990-2011 4.1* (2.7 to 5.5; p < 0.01) 4.1*
Sergipe 1990-2011 4.8* (3.3 to 6.4; p < 0.01) 4.8*
Ceará 1990-2011 4.5* (3.7 to 5.3; p < 0.01) 4.5*
Pernambuco 1990-2011 2.6* (2.0 to 3.1; p < 0.01) 2.6*
Brazil 1990-1994 2.5 (−1.3 to 6.5; p = 0.18) 1994-2011 0.3 (−0.1 to 0.7; p = 0.13) 0.3
Abbreviations: AAPC average annual percent change; APC annual percent change.
Joinpoint analyses with up to 1 joinpoints yielding up to 2 trend segments (Trends 1–2).
The AAPC is a weighted average of the APCs that is calculated by joinpoint regression.
Standardized mortality rate per 100,000 women.
*Statistically significant; p = 0.05.
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include: a lack of information on the disease, the time
interval between the first signs/symptoms and first
consultation (ranging from 1 to 60 months), delays in
diagnosing and treating breast cancer and the time be-
tween histopathological diagnosis and the beginning of
treatment.
The Amazona Project conducted by the Brazilian Group
for Studies in Breast Cancer (GBECAM) collected data
from 28 centers, including 4,912 cases of patients diag-
nosed with breast cancer in 2001 and 2006, representing
all the geographical regions of the country and allsocioeconomic levels. That study showed the disease to be
more advanced at diagnosis in the women treated in pub-
lic institutions, who had less access to modern therapies
and poorer survival compared to patients treated in pri-
vate institutions [16].
This study evaluated data from nationwide Brazilian
surveys, databases and local studies, and its results high-
light the gaps in information and the need to acquire
further knowledge and to conduct more studies on vari-
ous aspects. This report provides further information on
female breast cancer mortality in Brazil, thus permitting





















































































































Figure 3 Correlation between the variations in breast cancer mortality rates for women in Brazil. a. Human Development Index (2000)
from 1990 to 2000. (r = 0.28; p = .156). b. Human Development Index (2010) from 2001 to 2011. (r = -0.79; p<.001). Acre (AC), Alagoas (AL), Amapá
(AP), Amazonas (AM), Bahia (BA), Ceará (CE), Distrito Federal (DF), Espírito Santo (ES), Goiás (GO), Maranhão (MA), Mato Grosso (MT), Mato Grosso do
Sul (MS), Minas Gerais (MG), Pará (PA), Paraíba (PB), Paraná (PR); Pernambuco (PE), Piauí (PI), Rio de Janeiro (RJ), Rio Grande do Norte (RN), Rio Grande
do Sul (RS), Rondônia (RO), Roraima (RR), Santa Catarina (SC), São Paulo (SP), Sergipe (SE), Tocantins (TO).






















































Figure 4 Correlation between the Social Exclusion Index and the variations in breast cancer mortality rates for women in Brazil from
1990 to 2011. (r = -0.75; p<0.001). Acre (AC), Alagoas (AL), Amapá (AP), Amazonas (AM), Bahia (BA), Ceará (CE), Distrito Federal (DF), Espírito
Santo (ES), Goiás (GO), Maranhão (MA), Mato Grosso (MT), Mato Grosso do Sul (MS), Minas Gerais (MG), Pará (PA), Paraíba (PB), Paraná (PR);
Pernambuco (PE), Piauí (PI), Rio de Janeiro (RJ), Rio Grande do Norte (RN), Rio Grande do Sul (RS), Rondônia (RO), Roraima (RR), Santa Catarina
(SC), São Paulo (SP), Sergipe (SE), Tocantins (TO).
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services. Although the treatment options for breast can-
cer are effective, they unfortunately remain inaccessible
to many women living in developing areas. Lack of care
has resulted in unnecessary deaths. The unequal distribu-
tion of resources for breast cancer care and control for
women living in the same country is unacceptable.
Conclusions
Although there has been a trend toward stabilization in
female breast cancer mortality rates in Brazil, when the
mortality rate of each state is analyzed individually, con-
siderable inequalities are found, with rate decline or
stabilization in states with higher socioeconomic levels
and a substantial rate increase in those with lower socio-
economic levels. Reductions in these rates were found in
the more developed states, possibly reflecting better
healthcare.
Limitations
The use of the mortality data from the mortality data
system is subject to correction due to an under-
registration of deaths that is unfortunately common in
less developed areas. The demographic database maycontain errors that are inherent to data collection or to
the methodology used to calculate population-based
estimates. With respect to the breast cancer mortality
rate, there are always limitations to its use when a con-
siderable proportion of deaths take place without med-
ical care or because of other poorly defined causes.
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